|
|
 |
 |
|
Badrinath R. Konety, MD, MBA
Recent Publications |
Publications – 2008 |
 |
Agarwal, P.K., N. Sadetsky, B.R.
Konety,
M.I. Resnick, and P.R. Carroll, Treatment failure after primary
and salvage therapy for prostate cancer: likelihood, patterns
of care, and outcomes. Cancer, 2008. 112(2): p. 307-14. |
|
Choueiri, T.K., R. Dreicer, A. Paciorek,
P.R. Carroll, and B. Konety, A model that predicts the probability
of positive imaging in prostate cancer cases with biochemical
failure after initial definitive local therapy. J Urol, 2008.
179(3): p. 906-10; discussion 910. |
|
Dall'era, M.A. and B.R. Konety, Active
surveillance for low-risk prostate cancer: selection of patients
and predictors of progression. Nat Clin Pract Urol, 2008. |
|
Fradet, V. and B.R. Konety, A delay in
radical cystectomy of >3 months is not associated with
a worse clinical outcome. BJU Int, 2008. 101(2): p. 257-8;
author reply 258-9. |
|
Konety, B.R., Sickness and survival in
bladder cancer: is comorbidity the crystal ball? Eur Urol,
2008. 53(3): p. 465-7. |
| |
Publications – 2007 |
|
Allareddy, V., V. Allareddy, and B.R.
Konety, Specificity of procedure volume and in-hospital mortality
association. Ann Surg, 2007. 246(1): p. 135-9. |
|
Block, C.A., B. Erickson, C. Carney-Doebbling,
S. Gordon, B. Fallon, and B.R. Konety, Personality, treatment
choice and satisfaction in patients with localized prostate
cancer. Int J Urol, 2007. 14(11): p. 1013-8. |
|
Boorjian, S., J.E. Cowan, B.R. Konety,
J. DuChane, A. Tewari, P.R. Carroll, and C.J. Kane, Bladder
cancer incidence and risk factors in men with prostate cancer:
results from Cancer of the Prostate Strategic Urologic Research
Endeavor. J Urol, 2007. 177(3): p. 883-7; discussion 887-8. |
|
Cooperberg, M.R., S. Modak, and B.R. Konety, Trends in regionalization of
inpatient care for urological malignancies, 1988 to 2002. J Urol, 2007. 178(5):
p. 2103-8; discussion 2108.
10. |
|
Dall'Era, M. and B. Konety, The optimal
management of clinically localized prostate cancer: the debate
continues. Nat Clin Pract Urol, 2007. 4(9): p. 474-5. |
|
Davies, B.J. and B.R. Konety, Does periprostatic
nerve block with local anesthetic reduce pain during prostate
biopsy? Nat Clin Pract Urol, 2007. 4(2): p. 76-7. |
|
Joudi, F.N., V. Allareddy, C.J. Kane, and
B.R. Konety, Analysis of complications following partial
and total nephrectomy for renal cancer in a population based
sample. J Urol, 2007. 177(5): p. 1709-14. |
|
Konety, B.R. and V. Allareddy, Influence
of post-cystectomy complications on cost and subsequent outcome.
J Urol, 2007. 177(1): p. 280-7; discussion 287. |
|
Konety, B.R., V. Allareddy, and P.R. Carroll,
Factors affecting outcomes after radical cystectomy in African
Americans. Cancer, 2007. 109(3): p. 542-8. |
|
Konety, B.R., G.F. Joyce, and M. Wise,
Bladder and upper tract urothelial cancer. J Urol, 2007.
177(5): p. 1636-45.
|
|
Konety, B.R., N. Sadetsky, and P.R.
Carroll, Recovery of urinary continence following radical
prostatectomy: the impact of prostate volume--analysis
of data from the CaPSURE Database. J Urol, 2007. 177(4):
p. 1423-5; discussion 1425-6.
|
| |
Publications – 2006 |
|
Allareddy, V., J. Kennedy, M.M. West, and
B.R. Konety, Quality of life in long-term survivors of bladder
cancer. Cancer, 2006. 106(11): p. 2355-62. |
|
Allareddy, V. and B.R.
Konety, Characteristics
of patients and predictors of in-hospital mortality after
hospitalization for head and neck cancers. Cancer, 2006.
106(11): p. 2382-8. |
|
Block, C.A., L. Dahmoush, and B.R.
Konety,
Cutaneous metastases from transitional cell carcinoma of
the bladder. Urology, 2006. 67(4): p. 846 e15-7. |
|
Dyche, D.J., J. Ness, M. West, V. Allareddy,
and B.R. Konety, Prevalence of prostate specific antigen
testing for prostate cancer in elderly men. J Urol, 2006.
175(6): p. 2078-82. |
|
Greene, K.L., A. Berry, and B.R. Konety,
Diagnostic Utility of the ImmunoCyt/uCyt+ Test in Bladder
Cancer. Rev Urol, 2006. 8(4): p. 190-7. |
|
Joslyn, S.A. and B.R. Konety, Impact of
extent of lymphadenectomy on survival after radical prostatectomy
for prostate cancer. Urology, 2006. 68(1): p. 121-5. |
|
Joudi, F.N., L. Dahmoush, D.M. Spector,
and B.R. Konety, Complete response of bony metastatic bladder
urothelial cancer to neoadjuvant chemotherapy and cystectomy.
Urol Oncol, 2006. 24(5): p. 403-6. |
|
Joudi, F.N., B.J. Smith, M.A. O'Donnell,
and B.R. Konety, The impact of age on the response of patients
with superficial bladder cancer to intravesical immunotherapy.
J Urol, 2006. 175(5): p. 1634-9; discussion 1639-40. |
|
Konety, B.R., Prostate-specific antigen
testing in the elderly: a hard habit to kick? BJU Int, 2006.
97(1): p. 4-5. |
|
Konety, B.R., Bladder cancer prevention--could
a carrot be the stick? J Urol, 2006. 176(3): p. 864-5. |
|
Konety, B.R., Molecular markers in bladder
cancer: a critical appraisal. Urol Oncol, 2006. 24(4): p.
326-37. |
|
Konety, B.R., V. Allareddy, and H. Herr,
Complications after radical cystectomy: analysis of population-based
data. Urology, 2006. 68(1): p. 58-64. |
|
Konety, B.R., V. Allareddy, S. Modak, and
B. Smith, Mortality after major surgery for urologic cancers
in specialized urology hospitals: are they any better? J
Clin Oncol, 2006. 24(13): p. 2006-12. |
|
Konety, B.R., V.J. Sharp, M. Verma, and
R.D. Williams, Practice patterns in screening and management
of prostate cancer in elderly men. Urology, 2006. 68(5):
p. 1051-6. |
|
Lee, D.K., V. Allareddy, A. O'Donnell M,
R.D. Williams, and B.R. Konety, Does the interval between
prostate biopsy and radical prostatectomy affect the immediate
postoperative outcome? BJU Int, 2006. 97(1): p. 48-50. |
|
Lubaroff, D.M., B.
Konety, B.K. Link, T.L.
Ratliff, T. Madsen, M. Shannon, D. Ecklund, and R.D. Williams,
Clinical protocol: phase I study of an adenovirus/prostate-specific
antigen vaccine in men with metastatic prostate cancer. Hum
Gene Ther, 2006. 17(2): p. 220-9. |
|
Urakami, S., H. Shiina, H. Enokida, T.
Kawakami, T. Tokizane, T. Ogishima, Y. Tanaka, L.C. Li, L.A.
Ribeiro-Filho, M. Terashima, N. Kikuno, H. Adachi, T. Yoneda,
H. Kishi, K. Shigeno, B.R. Konety, M. Igawa, and R. Dahiya,
Epigenetic inactivation of Wnt inhibitory factor-1 plays
an important role in bladder cancer through aberrant canonical
Wnt/beta-catenin signaling pathway. Clin Cancer Res, 2006.
12(2): p. 383-91. |
|
Walter, L.C., D. Bertenthal, K. Lindquist,
and B.R. Konety, PSA screening among elderly men with limited
life expectancies. Jama, 2006. 296(19): p. 2336-42. |
| |
return
to top
|
|
|
|
|
|
|
